Distinct Tumorigenic Potential of abl and raf in B Cell Neoplasia: abl Activates the IL-6 Signaling Pathway

This publication has 59 references indexed in Scilit:

• Coupling Protein Design andin VitroSelection Strategies: Improving Specificity and Affinity of a Designed β-protein IL-6 Antagonist
  Journal of Molecular Biology, 1996
• The Plasmacytoma Growth Inhibitor Restrictin-P Is an Antagonist of Interleukin 6 and Interleukin 11
  Journal of Biological Chemistry, 1995
• The effects of antiinflammatory and antiallergic drugs on cytokine release after stimulation of human whole blood by lipopolysaccharide and zymosan A
  Inflammation Research, 1995
• Induction of Plasmacytomas With Silicone Gel Genetically Susceptible Strains of Mice
  JNCI Journal of the National Cancer Institute, 1994
• Interleukin-6-Induced Tyrosine Phosphorylation of Multiple Proteins in Murine Hematopoietic Lineage Cells
  Biochemical and Biophysical Research Communications, 1994
• The Role of Interleukin-6 in Mucosal IgA Antibody Responses in Vivo
  Science, 1994
• Stat3: a STAT Family Member Activated by Tyrosine Phosphorylation in Response to Epidermal Growth Factor and Interleukin-6
  Science, 1994
• Anti‐human interleukin‐6 receptor antibody inhibits human myeloma growth in vivo
  European Journal of Immunology, 1992
• Molecular cloning and expression of an IL-6 signal transducer, gp130
  Cell, 1990
• Induction of Plasma Cell Tumours in BALB/c Mice with 2,6,10,14-Tetramethylpentadecane (Pristane)
  Nature, 1969